TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of Tailored Physical Training Intervention (Prehabilitation) in High-risk Patients Underwent Major Abdominal Surgery on Postoperative Complications: Randomized Controlled Trial
Brief Summary: Despite recent advances, morbidity and mortality associated to major abdominal surgery is significant. A poor physical condition and functional status reduces the ability of a person to cope, mentally and physically, with hospitalization and surgery and may compromise functional recovery, potentially leading to postoperative complications and death. Prehabilitation aims to enhance functional capacity preoperatively for better toleration of surgery and to facilitate recovery and eventually the prognosis of the surgical patient. Whereas the benefits of cardiopulmonary fitness programs are well established, the accessibility, sustainability of effects, and impact on the surgical outcome of these programs are unsolved issues. Wellness programs based on integrated care services supported by Information and Communication Technology (ICT) can overcome such limitations. The investigators hypothesized that a prehabilitation program, inducing beneficial effects on exercise capacity, may improve the surgical outcome in high-risk patients. Moreover, ICT support may contribute to increase the adherence and sustainability of this intervention.


Options:
A: Arm Label: intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: quality of life pathway | Arm Label: control group; Type: PLACEBO_COMPARATOR; Interventions: Other: placebo control | Intervention Type: BEHAVIORAL; Name: quality of life pathway; Assigned to Arm(s): intervention group | Intervention Type: OTHER; Name: placebo control; Assigned to Arm(s): control group
B: Arm Label: Prehabilitation; Type: OTHER; Interventions: Behavioral: Prehabilitation | Arm Label: Standard Counseling; Type: OTHER; Interventions: Behavioral: Standard counseling | Intervention Type: BEHAVIORAL; Name: Prehabilitation; Assigned to Arm(s): Prehabilitation | Intervention Type: BEHAVIORAL; Name: Standard counseling; Assigned to Arm(s): Standard Counseling
C: Arm Label: Pre and postoperative exercise; Type: EXPERIMENTAL; Interventions: Other: Physical activity | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physical activity; Assigned to Arm(s): Pre and postoperative exercise
D: Arm Label: Prehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prehabilitation | Arm Label: No-intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prehabilitation; Assigned to Arm(s): Prehabilitation

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Effectiveness of Tailored Physical Training Intervention (Prehabilitation) in High-risk Patients Underwent Major Abdominal Surgery on Postoperative Complications: Randomized Controlled Trial
Brief Summary: Despite recent advances, morbidity and mortality associated to major abdominal surgery is significant. A poor physical condition and functional status reduces the ability of a person to cope, mentally and physically, with hospitalization and surgery and may compromise functional recovery, potentially leading to postoperative complications and death. Prehabilitation aims to enhance functional capacity preoperatively for better toleration of surgery and to facilitate recovery and eventually the prognosis of the surgical patient. Whereas the benefits of cardiopulmonary fitness programs are well established, the accessibility, sustainability of effects, and impact on the surgical outcome of these programs are unsolved issues. Wellness programs based on integrated care services supported by Information and Communication Technology (ICT) can overcome such limitations. The investigators hypothesized that a prehabilitation program, inducing beneficial effects on exercise capacity, may improve the surgical outcome in high-risk patients. Moreover, ICT support may contribute to increase the adherence and sustainability of this intervention.


Options:
A: Arm Label: Exercise Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise Intervention | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise Intervention; Assigned to Arm(s): Exercise Intervention
B: Arm Label: Prehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Prehabilitation | Arm Label: No-intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Prehabilitation; Assigned to Arm(s): Prehabilitation
C: Arm Label: Prehabilitation; Type: OTHER; Interventions: Behavioral: Prehabilitation | Arm Label: Standard Counseling; Type: OTHER; Interventions: Behavioral: Standard counseling | Intervention Type: BEHAVIORAL; Name: Prehabilitation; Assigned to Arm(s): Prehabilitation | Intervention Type: BEHAVIORAL; Name: Standard counseling; Assigned to Arm(s): Standard Counseling
D: Arm Label: Exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Exercise programme | Arm Label: No Exercise; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Exercise programme; Assigned to Arm(s): Exercise

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Efficacy Study of Liposomal Amphotericin in Disseminated Leishmaniasis
Brief Summary: Disseminated leishmaniasis (DL) is an emerging and severe form of leishmaniasis, with increasing prevalence in Bahia, Brasil. It is characterized by multiple acneiform, papular and ulcerated lesions localized on the face, chest, abdomen and extremities. The number of lesions ranges from 10 to hundreds, and mucosal disease has been documented in more than 40% of the cases.

DL is a hard to cure disease and therapeutic failure with pentavalent antimony has been documented in up to 70% of the cases caused by L. braziliensis in the endemic area of Corte de Pedra, Bahia. The majority of DL patients need several courses of antimony or the use of high dose of Amphotericin B desoxicolate to cure. Therefore DL patients are exposed to relevant drug toxicity, high morbidity due to a long lasting disease, with an important socio-economic impact. Our hypothesis is that liposomal Amphotericin B has a higher cure rate than historic cure rates of pentavalent antimony in the treatment of disseminated leishmaniasis.


Options:
A: Intervention Type: DRUG; Name: Anti-helminthic; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: meglumine antimony; Assigned to Arm(s): N/A
B: Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Miltefosine | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Meglumine antimoniate | Intervention Type: DRUG; Name: Miltefosine; Assigned to Arm(s): Group 1 | Intervention Type: DRUG; Name: Meglumine antimoniate; Assigned to Arm(s): Group 2
C: Arm Label: Liposomal Amphotericin; Type: EXPERIMENTAL; Interventions: Drug: Liposomal Amphotericin B | Intervention Type: DRUG; Name: Liposomal Amphotericin B; Assigned to Arm(s): Liposomal Amphotericin
D: Arm Label: Single dose of Pentamidine; Type: EXPERIMENTAL; Interventions: Drug: Single dose of Pentamidine | Arm Label: Two doses of Pentamidine; Type: EXPERIMENTAL; Interventions: Drug: Two doses of Pentamidine | Arm Label: Three doses of Pentamidine; Type: EXPERIMENTAL; Interventions: Drug: Three doses of Pentamidine | Intervention Type: DRUG; Name: Single dose of Pentamidine; Assigned to Arm(s): Single dose of Pentamidine | Intervention Type: DRUG; Name: Two doses of Pentamidine; Assigned to Arm(s): Two doses of Pentamidine | Intervention Type: DRUG; Name: Three doses of Pentamidine; Assigned to Arm(s): Three doses of Pentamidine

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Brief Summary: A study to evaluate levosimendan compared with placebo in reducing the composite event rate of all-cause death, perioperative MI, need for new dialysis, or use of mechanical assist (IABP, LVAD or ECMO) in subjects with reduced ejection fraction undergoing cardiac surgery on cardiopulmonary bypass (CPB).


Options:
A: Intervention Type: DRUG; Name: levosimendan; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: dobutamine; Assigned to Arm(s): N/A
B: Intervention Type: DRUG; Name: Tilarginine Acetate Injection intravenous infusion; Assigned to Arm(s): N/A
C: Intervention Type: DRUG; Name: Levosimendan; Assigned to Arm(s): N/A
D: Arm Label: Levosimendan; Type: EXPERIMENTAL; Interventions: Drug: Levosimendan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Levosimendan; Assigned to Arm(s): Levosimendan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Double-Blind, Randomized, Placebo-Controlled Study of Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass
Brief Summary: A study to evaluate levosimendan compared with placebo in reducing the composite event rate of all-cause death, perioperative MI, need for new dialysis, or use of mechanical assist (IABP, LVAD or ECMO) in subjects with reduced ejection fraction undergoing cardiac surgery on cardiopulmonary bypass (CPB).


Options:
A: Arm Label: L; Type: EXPERIMENTAL; Interventions: Drug: levosimendan | Arm Label: P; Type: EXPERIMENTAL; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: levosimendan; Assigned to Arm(s): L | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): P
B: Arm Label: Normal saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: Normal saline | Arm Label: Milrinone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Milrinone | Intervention Type: DRUG; Name: Milrinone; Assigned to Arm(s): Milrinone | Intervention Type: DRUG; Name: Normal saline; Assigned to Arm(s): Normal saline
C: Arm Label: Levosimendan; Type: EXPERIMENTAL; Interventions: Drug: Levosimendan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Levosimendan; Assigned to Arm(s): Levosimendan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: levosimendan; Type: ACTIVE_COMPARATOR; Interventions: Drug: levosimendan | Arm Label: placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: levosimendan; Assigned to Arm(s): levosimendan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): placebo

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Incidence of Urinary Retention in Orthopedic Patients Under Spinal Anesthesia
Brief Summary: The participants were hospitalized in Orthopedic and Traumatology Departments in Military Institute of Medicine, Warsaw, Poland.

The inclusion criteria were (1) age to 40 year-old, (2) no history of urologic problems, and (3) surgery under spinal anesthesia. All the patients where (1) opioids were administered during the surgery, (2) general anesthesia was necessary, and (3) the urinary bladder catheterization was perform during the surgery were excluded from the study.

The participants were randomly divided into the study and control groups. No oral premedication was administered. All the patients were asked to empty their urinary bladders before arrival to the operating theatre. When the standard monitoring (continuous electrocardiogram, noninvasive blood pressure, pulse oximetry) was started, intravenous premedication with midazolam was administered and lumbar spinal anesthesia with hyperbaric 0.5% solution of bupivacaine hydrochloride was performed.

In the study group, but not in the the control one, the 40 mg of drotaverine hydrochloride was administered intramuscularly. The decresed intravascular volume was corrected with cristalloids. During the surgery the adequate, not deeper than II grade according to Ramsay scale, level of sedationt was obtained with midazolam and/or propofol. All the participants received a questionaire in which we asked the questions about (1) the duration of anesthesia, (2) the time of micturition, (3) the time when discomfort or pain appeared in the lower abdomen, (4) the incidence of the urinary bladder catheterization and time to catheterization. On the next day after the surgery the questionaires were collected. In cases, when the patient's dischaged from the hospital was planned during the weekend, he or she was asked to pass on the questionaire to the nurses.


Options:
A: Arm Label: Drotaverine; Type: N/A; Interventions: N/A | Arm Label: Control; Type: N/A; Interventions: N/A
B: Arm Label: Foley; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Foley; Type: ACTIVE_COMPARATOR; Interventions: Other: No Foley | Intervention Type: OTHER; Name: No Foley; Assigned to Arm(s): No Foley
C: Arm Label: 24 hour postop catheter removal; Type: EXPERIMENTAL; Interventions: Drug: Prazosin given 6 hours prior to catheter removal in the 24 hour group | Arm Label: 72 hour postoperative catheter removal; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Prazosin given 6 hours prior to catheter removal in the 24 hour group; Assigned to Arm(s): 24 hour postop catheter removal
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: postoperative catheterization | Arm Label: 2.; Type: ACTIVE_COMPARATOR; Interventions: Procedure: postoperative catheterization | Intervention Type: PROCEDURE; Name: postoperative catheterization; Assigned to Arm(s): 1, 2.

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Brief Summary: We tested two interventions to improve the accuracy of medication histories obtained at hospital admission. The interventions target elderly and chronically ill patients prone to erroneous medication histories and resultant medication errors. For targeted patients, we tested the effect of using pharmacists and pharmacy technicians to obtain an initial medication history. This was studied using a randomized controlled trial of usual care (which involves nurses and physicians) vs usual care + pharmacists vs usual care + pharmacy technicians to obtain an admission medication history.

The overarching hypothesis was that by leveraging pharmacists and pharmacy technicians we can minimize admission medication history errors and related downstream events.


Options:
A: Arm Label: Pharmaceutical care program; Type: EXPERIMENTAL; Interventions: Other: Pharmaceutical Care Program | Arm Label: Standard Care; Type: OTHER; Interventions: Other: Standard Care | Intervention Type: OTHER; Name: Pharmaceutical Care Program; Assigned to Arm(s): Pharmaceutical care program | Intervention Type: OTHER; Name: Standard Care; Assigned to Arm(s): Standard Care
B: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I
C: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pharmacist obtains home med hx; Type: EXPERIMENTAL; Interventions: Other: Pharmacist obtains admission medication history | Arm Label: Pharm tech obtains home med hx; Type: EXPERIMENTAL; Interventions: Other: Pharmacy technician obtains admission medication history | Intervention Type: OTHER; Name: Pharmacist obtains admission medication history; Assigned to Arm(s): Pharmacist obtains home med hx | Intervention Type: OTHER; Name: Pharmacy technician obtains admission medication history; Assigned to Arm(s): Pharm tech obtains home med hx
D: Arm Label: Pre-intervention; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Mentored medication reconciliation quality improvement | Intervention Type: OTHER; Name: Mentored medication reconciliation quality improvement; Assigned to Arm(s): Intervention

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pharmacists and Pharmacy Technicians to Improve Admission Medication History Accuracy
Brief Summary: We tested two interventions to improve the accuracy of medication histories obtained at hospital admission. The interventions target elderly and chronically ill patients prone to erroneous medication histories and resultant medication errors. For targeted patients, we tested the effect of using pharmacists and pharmacy technicians to obtain an initial medication history. This was studied using a randomized controlled trial of usual care (which involves nurses and physicians) vs usual care + pharmacists vs usual care + pharmacy technicians to obtain an admission medication history.

The overarching hypothesis was that by leveraging pharmacists and pharmacy technicians we can minimize admission medication history errors and related downstream events.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Procedure: New technology - PAML | Intervention Type: PROCEDURE; Name: New technology - PAML; Assigned to Arm(s): Intervention
B: Arm Label: 1; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease | Intervention Type: BEHAVIORAL; Name: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Assigned to Arm(s): 2
C: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Pharmacist obtains home med hx; Type: EXPERIMENTAL; Interventions: Other: Pharmacist obtains admission medication history | Arm Label: Pharm tech obtains home med hx; Type: EXPERIMENTAL; Interventions: Other: Pharmacy technician obtains admission medication history | Intervention Type: OTHER; Name: Pharmacist obtains admission medication history; Assigned to Arm(s): Pharmacist obtains home med hx | Intervention Type: OTHER; Name: Pharmacy technician obtains admission medication history; Assigned to Arm(s): Pharm tech obtains home med hx
D: Arm Label: I; Type: EXPERIMENTAL; Interventions: Other: Drug review 80+ -To reduce usage of hospital care | Arm Label: C; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Drug review 80+ -To reduce usage of hospital care; Assigned to Arm(s): I

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The CORE-trial: a Pragmatic Randomized Controlled Trial in Primary Care Investigating Effectiveness and Cost-effectiveness of the Check Your Health Preventive Programme Offered Population-wide to 30-49 Years
Brief Summary: Check your health is a prevention intervention designed to create awareness and action on health condition with focus at physical activity at a population-level to 30-49 years of age. It consists of a behavioural and clinical examination followed by either (I) referral to a health promoting consultation in general practice (II) targeted behavioural programmes at the local Health Centre or (III ) no need for follow-up; stratified after risk-profile. The CORE trial (Check your health) aim to investigate effectiveness on health and social outcomes of the preventive health check and to establish the cost-effectiveness according to life years gained; direct costs and total health costs. A pragmatic cluster randomised controlled trial has been established to meet the aims and in total 10.600 individuals from 35 practices have been randomized in to two groups that will be invited in 2013-14 and 2017-18 respectively. The group offered the preventive health check in 2013-14 will constitute the intervention group and the group examined in 2017 - 18 the control group. A follow up of the intervention group in 2017 - 18 will provide data for the intention to treat analysis revealing the effect. Outcome measures are level of physical activity, risk of getting cardiovascular disease, sick leave and labor market attachment.


Options:
A: Arm Label: Immediate Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Immediate Intervention | Arm Label: Wait List Intervention; Type: OTHER; Interventions: Other: Wait List Intervention | Intervention Type: BEHAVIORAL; Name: Immediate Intervention; Assigned to Arm(s): Immediate Intervention | Intervention Type: OTHER; Name: Wait List Intervention; Assigned to Arm(s): Wait List Intervention
B: Arm Label: Health check; Type: EXPERIMENTAL; Interventions: Other: Health check | Arm Label: No invitation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Health check; Assigned to Arm(s): Health check
C: Arm Label: Health checks with fitness testing; Type: EXPERIMENTAL; Interventions: Behavioral: Health checks with fitness testing | Arm Label: Health checks without fitness testing; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Health checks without fitness testing | Intervention Type: BEHAVIORAL; Name: Health checks with fitness testing; Assigned to Arm(s): Health checks with fitness testing | Intervention Type: BEHAVIORAL; Name: Health checks without fitness testing; Assigned to Arm(s): Health checks without fitness testing
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Procedure: optimised treatment | Intervention Type: PROCEDURE; Name: optimised treatment; Assigned to Arm(s): Intervention

Answer: B